Egypt Alerts & Recalls Egypt September 5, 2026 Egypt orders Class I recall of Appavisc HVPFS batch after failing lab testing The Egyptian Drug Authority (EDA) has ordered a Class I recall of one batch of Appavisc HVPFS, manufactured by Chironephre… Read the notice →
Somalia August 24, 2026 Somalia Pharmaceutical Business Council Warns Falsified Brands Could Damage Reputation of Pakistani Medicines SPBC urges Pakistan's pharmaceutical industry to address alleged brand falsification in Somalia, warning that the conduct of individual traders could undermine confidence in legitimate… Read the notice →
Mozambique August 21, 2026 Mozambique withdraws Remedica methyldopa tablets after black spots found Mozambique’s National Medicines Regulatory Authority (ANARME) has ordered the immediate suspension of sale and withdrawal from the national market of… Read the notice →